Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

NCT01409005 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Metastatic or Recurrent Colorectal Cancer
Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan
Salvage Chemotherapy

Interventions

DRUG: Gemcitabine and UFTE chemotherapy

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]